title: Ibrutinib holds promise for patients with 17p deletion CLL.
authors.affiliation: Strategic Research Program on Chronic Lymphocytic Leukaemia, Division of Experimental Oncology, IRCCS Ospedale San Raffaele and Università Vita-Salute San Raffaele, Milan, Italy. Electronic address: ghia.paolo@hsr.it.
authors.forename: Paolo
authors.initials: P
authors.lastname: Ghia
mesh_terms: D000225:Adenine / Q000031:analogs & derivatives; D002872:Chromosome Deletion; D006801:Humans; D015451:Leukemia, Lymphocytic, Chronic, B-Cell; D010880:Piperidines; D011720:Pyrazoles; D011743:Pyrimidines
chemical_list: D010880:Piperidines; D011720:Pyrazoles; D011743:Pyrimidines; C551803:ibrutinib; D000225:Adenine